Intravitreal Injections
Showing 1 - 25 of 4,865
Anxiety and Fear Trial in Manresa (Music)
Active, not recruiting
- Anxiety and Fear
- Music
-
Manresa, Barcelona, SpainEduard Pedemonte Sarrias
Jun 6, 2023
Dry Age-related Macular Degeneration Trial in Rome (Intravitreal injection of CB-PRP)
Recruiting
- Dry Age-related Macular Degeneration
- Intravitreal injection of CB-PRP
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023
Intravitreal Injection, Ocular Rinse, Age-Related Macular Degeneration Trial in Oklahoma City (OSDI questionnaire, SPEEDII
Completed
- Intravitreal Injection
- +4 more
- OSDI questionnaire
- SPEEDII questionnaire
-
Oklahoma City, OklahomaDean McGee Eye Institute
Nov 7, 2022
Retinal Disease Trial in San Antonio (IRX-101, Providone-Iodine)
Recruiting
- Retinal Disease
-
San Antonio, TexasR. Gary Lane, II MD
Mar 1, 2023
Diabetic Macular Edema, Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Banha (Anti-vascular endothelial
Recruiting
- Diabetic Macular Edema
- +4 more
- Anti-vascular endothelial growth factors (Anti-VEGFs)
-
Banhā, Benha, EgyptAhmed Abdelshafy Tabl
Aug 8, 2022
Neovascular Age-related Macular Degeneration Trial (Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule,
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule
- Intravitreal injections of 6 mg faricimab on a home optical coherence tomography-guided treatment schedule
- (no location specified)
Jun 6, 2023
Diabetic Macular Edema, Retinal Disease, Macular Edema Trial in United States (Aflibercept, foselutoclax)
Not yet recruiting
- Diabetic Macular Edema
- +8 more
-
Bakersfield, California
- +7 more
Aug 23, 2023
Safety and Effectiveness of Brolucizumab in Diabetic Macular
Not yet recruiting
- Diabetic Macular Edema
- brolucizumab
- (no location specified)
Jul 17, 2023
Radiation Retinopathy, Visual Impairment Trial (Faricimab, fluocinolone acetonide)
Not yet recruiting
- Radiation Retinopathy
- Visual Impairment
- Faricimab
- fluocinolone acetonide
- (no location specified)
Apr 25, 2023
Collateral Damage From COVID-19 Pandemic Observed in Patients
Completed
- Age Related Macular Degeneration
- +2 more
- Questionnaire
- Data collection up to 1 year
-
Ecully, France
- +3 more
Mar 2, 2022
Pain, Acute Trial in Giza (bupivacaine 0.5% and oxubuprocaine)
Completed
- Pain, Acute
- bupivacaine 0.5% and oxubuprocaine
-
Giza, Haram, EgyptResearch Institute of Ophthamology
Sep 10, 2022
Retinal Telangiectasis, Coats Disease Trial in France (Anti-VEGF injections of bevacizumab, Laser)
Recruiting
- Retinal Telangiectasis
- Coats Disease
- Anti-VEGF injections of bevacizumab
- Laser
-
Cergy-Pontoise, France
- +4 more
Dec 17, 2021
Proliferative Diabetic Retinopathy Trial in Beijing (preoperative intravitreal injections of ranibizumab or conbercept)
Completed
- Proliferative Diabetic Retinopathy
- preoperative intravitreal injections of ranibizumab or conbercept
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 7, 2022
Endophthalmitis Trial in Toronto (Tap and Inject (TAI), Pars Plana Vitrectomy (PPV))
Recruiting
- Endophthalmitis
- Tap and Inject (TAI)
- Pars Plana Vitrectomy (PPV)
-
Toronto, Ontario, CanadaSt. Michael's Hospital Eye Clinic
Apr 26, 2021
Radiation Retinopathy Trial in United States (0.5 mg ranibizumab, Targeted Retinal Photocoagulation (TRP))
Completed
- Radiation Retinopathy
- 0.5 mg ranibizumab
- Targeted Retinal Photocoagulation (TRP)
-
Dallas, Texas
- +3 more
Mar 24, 2021
Pachychoroid Neovasculopathy Trial (Three monthly injections of intravitreal aflibercept)
Not yet recruiting
- Pachychoroid Neovasculopathy
- Three monthly injections of intravitreal aflibercept
- (no location specified)
Dec 14, 2022
Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in Vienna (MacInfo presentation, Placebo
Recruiting
- Age-related Macular Degeneration
- +2 more
- MacInfo presentation
- Placebo presentation
-
Vienna, AustriaVienna Institute for Research in Ocular Surgery (VIROS), Hanusch
Jan 24, 2022
Diabetic Macular Edema Trial in Tehran (Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide,
Active, not recruiting
- Diabetic Macular Edema
- Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide
- Injections of 1.25 mg of intravitreal bevacizumab with artificial tears
-
Tehran, Iran, Islamic Republic ofOphthalmic Research Center
Oct 6, 2021
Intravitreal Injections, IVI Trial in Madison (Bromfenac, Artificial tears)
Completed
- Intravitreal Injections
- IVI
- Bromfenac
- Artificial tears
-
Madison, WisconsinUniversity of Wisconsin
Sep 24, 2020
Exudative Age-related Macular Degeneration Trial in United States (RBM-007 Injectable Solution, Aflibercept, Sham)
Completed
- Exudative Age-related Macular Degeneration
- RBM-007 Injectable Solution
- +2 more
-
Phoenix, Arizona
- +7 more
Feb 5, 2022
Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)
Terminated
- Dry Age-related Macular Degeneration
- +4 more
-
Phoenix, Arizona
- +28 more
Mar 22, 2022
Age-Related Macular Degeneration Trial in Philippines, United States (2.0 mg DE-122 Injectable Solution + Lucentis, 4.0 mg
Completed
- Age-Related Macular Degeneration
- 2.0 mg DE-122 Injectable Solution + Lucentis
- +2 more
-
Gilbert, Arizona
- +13 more
Jun 22, 2021